Search Results - "Tasset, C" :: K.UTB vyhledávací portál

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)

by Westhovens, R, Taylor, P C, Alten, R, Pavlova, D, Enríquez-Sosa, F, Mazur, M, Greenwald, M, Van der Aa, A, Vanhoutte, F, Tasset, C, Harrison, P
Published in Annals of the rheumatic diseases (01.06.2017)

Get full text

Journal Article

Loading…

Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)

by Kavanaugh, A, Kremer, J, Ponce, L, Cseuz, R, Reshetko, O V, Stanislavchuk, M, Greenwald, M, Van der Aa, A, Vanhoutte, F, Tasset, C, Harrison, P
Published in Annals of the rheumatic diseases (01.06.2017)

Get full text

Journal Article

Loading…

Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension

by Reich, K., Ortonne, J.-P., Gottlieb, A.B., Terpstra, I.J., Coteur, G., Tasset, C., Mease, P.
Published in British journal of dermatology (1951) (01.07.2012)

Get full text

Journal Article

Loading…

SAT0231 Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid arthritis

by Taylor, P. C., Tarrant, J., Zhao, L., Gindin, Y., Mirza, A., Harrison, P., Tasset, C., Galien, R., Van der Aa, A., Downie, B.
Published in Annals of the rheumatic diseases (01.06.2018)

Get full text

Journal Article

Loading…

AB0494 Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar PK and PD Profiles in Japanese and Caucasian Healthy Volunteers

by Namour, F., Vayssière, B., Galien, R., Fagard, L., Van der Aa, A., Harrison, P., Tasset, C.
Published in Annals of the rheumatic diseases (01.06.2015)

Get full text

Journal Article

Loading…

THU0167 The Effect of Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor on Patient-Reported Outcomes: Results from Two 24-Week Phase 2b Dose Ranging Studies

by Genovese, M., Westhovens, R., Kavanaugh, A., Meuleners, L., Van der, Aa A., Harrison, P., Tasset, C.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

Loading…

THU0123 Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach

by Namour, F., Tasset, C., van't Klooster, G., Diderichsen, P.M., Cox, E.
Published in Annals of the rheumatic diseases (01.06.2014)

Get full text

Journal Article

Loading…

AB0460 Glpg0634, A Selective JAK1 Inhibitor, Confirms Its Low Liability for Drug-Drug Interactions

by Namour, F., Desrivot, J., Tasset, C., Van der Aa, A., van't Klooster, G.
Published in Annals of the rheumatic diseases (01.06.2014)

Get full text

Journal Article

Loading…

OP0224 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study

by Westhovens, R., Alten, R., Pavlova, D., Enriquez Sosa, F.E., Mazur, M., Greenwald, M., Van der, Aa A., Vanhoutte, F., Tasset, C., Harrison, P.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

Loading…

THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study

by Kavanaugh, A., Ponce, L., Cseuz, R., Reshetko, O., Stanislavchuk, M., Greenwald, M., Van der, Aa A., Vanhoutte, F., Tasset, C., Harrison, P.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

Loading…

Acute chikungunya virus infection and asthma

by PAGANIN, F, TASSET, C, POUBEAU, P, COCHET, V, BORGHERINI, G
Published in The European respiratory journal (01.06.2010)

Get full text

Journal Article

Loading…

Brain tuberculoma in a 10-year-old child: the diagnosis is in the belly

by Vernaz, A, Enaud, L, Blanc, S, Stoven, C, Tasset, C, Losi, S, Andriolo, E, Piyaraly, S, Flodrops, H
Published in Archives de pédiatrie : organe officiel de la Société française de pédiatrie (01.08.2012)

Get full text

Journal Article

Loading…

Tuberculome cérébral chez une enfant de 10 ans diagnostiqué par biopsie d’une adénopathie abdominale

by Vernaz, A., Enaud, L., Blanc, S., Stoven, C., Tasset, C., Losi, S., Andriolo, E., Piyaraly, S., Flodrops, H.
Published in Archives de pédiatrie : organe officiel de la Société française de pédiatrie (01.08.2012)

Get full text

Journal Article

Loading…

OP0141 EFFECTS OF FILGOTINIB ON SPINAL LESIONS IN ANKYLOSING SPONDYLITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE TORTUGA TRIAL

by Baraliakos, X., Østergaard, M., Landewé, R. B. M., Barchuk, W., Liu, K., Tasset, C., Gilles, L., Hendrikx, T., Besuyen, R., Maksymowych, W. P.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

Loading…

THU0377 IMPACT OF FILGOTINIB ON STRUCTURAL LESIONS IN THE SACROILIAC JOINTS AT 12 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE DOUBLE-BLIND, RANDOMIZED TORTUGA TRIAL

by Maksymowych, W. P., Ǿstergaard, M., Landewé, R. B. M., Barchuk, W., Liu, K., Tasset, C., Gilles, L., Hendrikx, T., Besuyen, R., Baraliakos, X.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

Loading…

OP0229 Effect of baseline serum crp levels on clinical efficacy in rheumatoid arthritis patients treated with filgotinib: post-hoc analysis from two phase 2b studies

by Westhovens, R, Kavanaugh, A, Jamoul, C, Tasset, C, Harrison, P, Aa, A Van der
Published in Annals of the rheumatic diseases (01.06.2017)

Get full text

Journal Article

Loading…

FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR)

by Helliwell, P., Van den Bosch, F., Coates, L. C., Gladman, D. D., Tasset, C., Meuleners, L., Gilles, L., Gheyle, L., Trivedi, M., Alani, M., Besuyen, R., Mease, P. J.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

Loading…

FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS

by Husni, M. E., Gladman, D. D., Helliwell, P., Van den Bosch, F., Tasset, C., Meuleners, L., Gilles, L., Gheyle, L., Trivedi, M., Alani, M., Besuyen, R., Mease, P. J.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

Loading…

FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2)

by Gladman, D. D., Coates, L. C., Van den Bosch, F., Helliwell, P., Tasset, C., Meuleners, L., Gilles, L., Gheyle, L., Trivedi, M., Alani, M., Besuyen, R., Mease, P. J.
Published in Annals of the rheumatic diseases (01.06.2020)

Get full text

Journal Article

Loading…

THU0167 The Effect of Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor on Patient-Reported Outcomes: Results from Two 24-Week Phase 2b Dose Ranging Studies: Table 1

by Genovese, M., Westhovens, R., Kavanaugh, A., Meuleners, L., Van der, Aa A., Harrison, P., Tasset, C.
Published in Annals of the rheumatic diseases (01.06.2016)

Get full text

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database